Tytuł:

Public perception of innovative therapies and biopharmaceuticals in Poland and Europe

Inny tytuł:

Public perception of innovative therapies and biopharmaceuticals in Poland and Europe

Twórca:

Szlichcińska, Joanna

Wydawca:

Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS

Data wydania/powstania:

2007

Temat i słowa kluczowe:

biotechnology

Abstrakt:

Several reports and surveys of the perception of red biotechnology uses conducted in recent years show the complexity of European’s attitude to innovative therapies which might be used in medicine. Polish people, as well as the rest of European nations in general, support the development of gene therapy or pharmacogenetics, whereas the issues of stem cells research and uses of genetic information are still under discussion. The results of various questionnaires prove that a rise of the optimism level in this matter is necessary. It occurred that in order to build public acceptability and confidence in biotechnology policy, it is crucial to ensure the society that moral and ethical aspects are taken into consideration.

Czasopismo/Seria/cykl:

Biotechnologia, vol.77, 2 (2007)-.

Tom:

77

Zeszyt:

2

Strona pocz.:

128

Strona końc.:

136

Typ zasobu:

Text

Szczegółowy typ zasobu:

Article

Format:

application/pdf

Identyfikator zasobu:

0860-7796

Źródło:

Library of Institute of Bioorganic Chemistry PAS

Język:

pol

Język streszczenia:

eng

Zakres czasowy:

1988-2010

Prawa:

Creative Commons Attribution BY-SA 4.0 license

Zasady wykorzystania:

Copyright-protected material. [CC BY-SA 4.0] May be used within the scope specified in Creative Commons Attribution BY-SA 4.0 license, full text available at:

Digitalizacja:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Lokalizacja oryginału:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Dofinansowane ze środków:

Operational Program Digital Poland, 2014-2020, Measure 2.3: Digital accessibility and usefulness of public sector information; funds from the European Regional Development Fund and national co-financing from the state budget.

Dostęp:

Open